BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0860
+0.0160 (22.86%)
Sep 17, 2026, 3:34 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 25.81 million as of September 16, 2026. Its market cap has increased by 6.85% in one year.
Market Cap
25.81M
Enterprise Value
31.14M
Revenue
2.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 25.81M, a decrease of -50.10%. That is a compound annual growth rate of -12.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 25.81M | -33.22% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 505.18M |
| Healius | 308.62M |
| Monash IVF Group | 305.86M |
| Cryosite | 57.60M |
| Microba Life Sciences | 38.72M |
| Rhythm Biosciences | 29.02M |
| INOVIQ | 23.93M |
| Genetic Signatures | 18.17M |